🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
195.00
-4.33 (-2.17%)
At close: Nov 20, 2026, 4:00 PM EST
199.00
+4.00 (2.05%)
After-hours: Nov 20, 2026, 7:59 PM EST

Moderna Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,3651,8183,1096,67118,43517,675
Other Revenue
160126127177828796
2,5251,9443,2366,84819,26318,471
Revenue Growth
13.13%-39.93%-52.74%-64.45%4.29%2200.25%
Cost of Revenue
3,5864,0006,0079,5388,7114,608
Gross Profit
-1,061-2,056-2,771-2,69010,55213,863
Selling, General & Admin
9791,0181,1741,5491,132567
Operating Expenses
9791,0181,1741,5491,132567
Operating Income
-2,040-3,074-3,945-4,2399,42013,296
Interest Expense
-60-10-24--29-17
Interest & Investment Income
27131442542120018
Other Non Operating Income (Expenses)
-67-7-124-16-12
EBT Excluding Unusual Items
-1,835-2,763-3,551-3,9429,57513,285
Gain (Loss) on Sale of Investments
-4-5-56---
Pretax Income
-2,729-2,768-3,607-3,9429,57513,285
Income Tax Expense
6054-467721,2131,083
Net Income
-2,789-2,822-3,561-4,7148,36212,202
Net Income to Common
-2,789-2,822-3,561-4,7148,36212,202
Net Income Growth
-----31.47%-
Shares Outstanding (Basic)
397389384382394403
Shares Outstanding (Diluted)
397389384382416431
Shares Change
2.26%1.30%0.52%-8.17%-3.48%13.12%
EPS (Basic)
-7.03-7.25-9.27-12.3421.2230.28
EPS (Diluted)
-7.03-7.25-9.27-12.3420.1228.29
EPS Growth
-----28.88%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,970-2,065-4,055-3,8254,58113,336
Free Cash Flow Per Share
-4.97-5.31-10.56-10.0111.0130.94
Gross Margin
-42.02%-105.76%-85.63%-39.28%54.78%75.05%
Operating Margin
-80.79%-158.13%-121.91%-61.90%48.90%71.98%
Profit Margin
-110.45%-145.17%-110.04%-68.84%43.41%66.06%
Free Cash Flow Margin
-78.02%-106.22%-125.31%-55.86%23.78%72.20%
EBITDA
-1,783-2,859-3,756-3,6189,76813,528
EBITDA Margin
-70.61%-147.07%-116.07%-52.83%50.71%73.24%
D&A For EBITDA
257215189621348232
EBIT
-2,040-3,074-3,945-4,2399,42013,296
EBIT Margin
-80.79%-158.13%-121.91%-61.90%48.90%71.98%
Effective Tax Rate
----12.67%8.15%
Revenue as Reported
2,5251,9443,2366,84819,26318,471
Advertising Expenses
----121-
SEC Filings: 10-K · 10-Q